Valency Controlled Quantum Dots with Tunable Number of Biotin Binding Sites
Invention type: Technology
/
Case number: #12606B
A controlled valency semiconductor nanocrystal can have a desired number of compounds associated with it. The semiconductor nanocrystal can have exactly one compound associated with it, and the compound can have exactly one binding site for an affinity target. The semiconductor nanocrystal can be used to image single copies of cell-surface proteins.
Researchers
Mark Howarth
/
Wenhao Liu
/
Moungi Bawendi
/
Alice Ting
Departments: Department of Chemistry
Technology Areas: Biotechnology: Sensors & Monitoring / Chemicals & Materials: Nanotechnology & Nanomaterials / Diagnostics: Imaging Agents / Electronics & Photonics: Semiconductors / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
controlled modification of semiconductor nanocrystals
European Patent Convention | Granted | 2,165,185
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.